Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP771513.RAB4OprLZsbas9qzeZ4NVjUTdE51CmhzVYQ4DQlp8n1W4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP771513.RAB4OprLZsbas9qzeZ4NVjUTdE51CmhzVYQ4DQlp8n1W4130_assertion type Assertion NP771513.RAB4OprLZsbas9qzeZ4NVjUTdE51CmhzVYQ4DQlp8n1W4130_head.
- NP771513.RAB4OprLZsbas9qzeZ4NVjUTdE51CmhzVYQ4DQlp8n1W4130_assertion description "[It is suggested that, besides beta-adrenergic blockers and L-type calcium current channel blockers, an agent aimed at reduction of sarcoplasmic reticulum Ca(2+) ATPase uptake current may provide additional antiarrhythmic effect in patients with TS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP771513.RAB4OprLZsbas9qzeZ4NVjUTdE51CmhzVYQ4DQlp8n1W4130_provenance.
- NP771513.RAB4OprLZsbas9qzeZ4NVjUTdE51CmhzVYQ4DQlp8n1W4130_assertion evidence source_evidence_literature NP771513.RAB4OprLZsbas9qzeZ4NVjUTdE51CmhzVYQ4DQlp8n1W4130_provenance.
- NP771513.RAB4OprLZsbas9qzeZ4NVjUTdE51CmhzVYQ4DQlp8n1W4130_assertion SIO_000772 19855067 NP771513.RAB4OprLZsbas9qzeZ4NVjUTdE51CmhzVYQ4DQlp8n1W4130_provenance.
- NP771513.RAB4OprLZsbas9qzeZ4NVjUTdE51CmhzVYQ4DQlp8n1W4130_assertion wasDerivedFrom befree-2016 NP771513.RAB4OprLZsbas9qzeZ4NVjUTdE51CmhzVYQ4DQlp8n1W4130_provenance.
- NP771513.RAB4OprLZsbas9qzeZ4NVjUTdE51CmhzVYQ4DQlp8n1W4130_assertion wasGeneratedBy ECO_0000203 NP771513.RAB4OprLZsbas9qzeZ4NVjUTdE51CmhzVYQ4DQlp8n1W4130_provenance.